Page 56 - Genomic Medicine in Emerging Economies

References 45

Fugh-Berman, A., 2000. Herb-drug interactions. Lancet 355 (9198), 134–138.
Fushimi, H., Komatsu, K., Isobe, M., NAMBA, T., 1997. Application of PCR-RFLP and MASA analy-
ses on 18S ribosomal RNA gene sequence for the identification of three ginseng drugs. Biol.
Pharm. Bull. 20 (7), 765–769.
Health Statistical Year Book, 2007. Beijing: Ministry of Health; 2007. Available from: www.moh.
gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/200807/37168.htm.
Ho, I., Leung, F., 2002. Isolation and characterization of repetitive DNA sequences from Panax
ginseng. Mol. Genet. Genomics 266 (6), 951–961.
Hon, C.C., Chow, Y.C., Zeng, F.Y., Leung, F.C., 2003. Genetic authentication of ginseng and other
traditional Chinese medicine. Acta Pharm. Sin. 24 (9), 841–846.
Hu, X., Cook, S., Salazar, M.A., 2008. Internal migration and health in China. Lancet 372 (9651),
1717–1719.
Hu, M., Wang, D.Q., Xiao, Y.J., Mak, V., Tomlinson, W.L.B., 2012. Herb-drug interactions: methods
to identify potential influence of genetic variations in genes encoding drug metabolizing en-
zymes and drug transporters. Curr. Pharm. Biotechnol. 13 (9), 1718–1730.
Jiang, J., Sliva, D., 2010. Novel medicinal mushroom blend suppresses growth and invasiveness of
human breast cancer cells. Intl. J. Oncol. 37 (6), 1529.
Jiang, B., Wang, W.Z., Chen, H., Hong, Z., Yang, Q.D., Wu, S.P., et al., 2006. Incidence and trends
of stroke and its subtypes in China. Stroke 37 (1), 63–65.
King, M., 2005. China’s infamous one-child policy. Lancet 365 (9455), 215–216.
Konkimalla, V.B., Blunder, M., Korn, B., Soomro, S.A., Jansen, H., Chang, W., et al., 2008. Effect of
artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7
mouse macrophage cells. Nitric Oxide 19 (2), 184–191.
Konoshima, T., Takasaki, M., Tokuda, H., Masuda, K., Yoko, A.R., Shiojima, K., et al., 1996. Anti-
tumor-promoting activities of triterpenoids from ferns. I. Biol. Pharm. Bull. 19 (7), 962–965.
Kupaev, V., Borisov, O., Marutina, E., Yan, Y.X., Wang, W., 2016. Integration of suboptimal health
status and endothelial dysfunction as a new aspect for risk evaluation of cardiovascular dis-
ease. EPMA J. 7 (1), 19.
Liang, K.W., Yin, S.C., Ting, C.T., Lin, S.J., Hsueh, C.M., Chen, C.Y., et al., 2008. Berberine inhibits
platelet-derived growth factor-induced growth and migration partly through an AMPK-depen-
dent pathway in vascular smooth muscle cells. Eur. J. Pharmacol. 590 (1), 343–354.
Lichti-Kaiser, K., Staudinger, J.L., 2008. The traditional Chinese herbal remedy Tian Xian activates
pregnane X receptor and induces CYP3A gene expression in hepatocytes. Drug Metab. Dispos.
36 (8), 1538–1545.
Liu, Y., Rao, K., Fei, J., 1998. Economic transition and health transition: comparing China and
Russia. Health Policy 44 (2), 103–122.
Lu, J.P., Knezevic, A., Wang, Y.X., Rudan, I., Campbell, H., Zou, Z.K., et al., 2011. Screening novel
biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han
and Croatian populations. J. Proteome Res. 10 (11), 4959–4969.
Mao, X., Wertz, D.C., 1997. China’s genetic services providers’ attitudes towards several ethical is-
sues: a cross-cultural survey. Clin. Genet. 52 (2), 100–109.
McLachlan, F., Timofeeva, M., Bermingham, M., Wild, S., Rudan, I., 2016. A case-control study in
an Orcadian population investigating the relationship between human plasma N-glycans and
metabolic syndrome. J. Glycomics Lipidomics 6 (139), 2153–2637.
Ministry of Health. Urban Medical Service Study in China – Survey Data on Medical Care Demand
and Utilization from Nine Provinces and Municipalities. Beijing: Ministry of Health; 1989.